Pfizer drug trial victims start to receive compensation
People in Nigeria have started to receive long-awaited compensation payments from Pfizer after a botched drug trial.
Eleven children died and dozens more developed disabilities during a 1996 trial of an experimental drug treatment for meningitis.
Four families have received $175,000 in the first batch of payouts after they obtained DNA evidence their children’s deaths were caused from the trial.
READ MORE FROM THE WDM CONTENT NETWORK:
To read the latest edition of Healthcare Global, click here
- Charity launches mass measles vaccination programme
- Long working hours linked to alcohol abuse
- E.Coli research to get €2 million EU investment
However, the company has been criticised for only compensating four families in the initial round of payouts despite 200 children taking part in the trial.
The money for the compensation has come from a $35 million fund created as part of the settlement between Pfizer and the northern Kano state in Nigeria where the trial took place.
As part of the settlement Pfizer has also agreed to fund health projects in the Kano region.
However, the company is still insistent the deaths were caused by meningitis and not the drugs it was testing.
In a statement the pharmaceutical company said: “This is the first step in a multi-phase review process by which the independent board of trustees that manages the fund will deliver payment to all other qualified claimants.
“We thank them for their commitment and dedication to seeing this process through in the most timely and transparent way possible.”
- Pfizer's Covid vaccine set to be first to gain approvalMedical Devices & Pharma
- Pfizer and GSK are merging their consumer health units, leading to $12.7bn in combined salesDigital Healthcare
- Bain Capital and Pfizer launch a new biopharma companyMedical Devices & Pharma
- Pfizer’s announces new CEOTeleHealth & COVID-19